The current COVID-19 pandemic challenges oncologists to profoundly re-organize
oncological care in order to dramatically reduce hospital visits and admissions and therapy …

Rectal cancer treatment has evolved during the past 40 years with the use of a standardized
surgical technique for tumour resection: total mesorectal excision. A dramatic reduction in …

This selection from the NCCN Guidelines for Rectal Cancer focuses on management of
malignant polyps and resectable nonmetastatic rectal cancer because important updates …

Several decades ago, colorectal cancer was infrequently diagnosed. Nowadays, it is the
world's fourth most deadly cancer with almost 900 000 deaths annually. Besides an ageing …

The American Society of Colon and Rectal Surgeons (ASCRS) is dedicated to ensuring high-
quality patient care by advancing the science, prevention, and management of disorders …

The incidence of rectal cancer in the European Union is $125 000 per year, ie $35% of the
total colorectal cancer incidence, reflecting 15–25 cases/100000 population per year and is …

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer
address diagnosis, staging, surgical management, perioperative treatment, management of …

Background Treatment of locally advanced rectal cancer with chemoradiotherapy, surgery,
and adjuvant chemotherapy controls local disease, but distant metastases remain common …

Background Radiotherapy reduces the risk of local recurrence in rectal cancer. However, the
optimal radiotherapy fractionation and interval between radiotherapy and surgery is still …

Background Total neoadjuvant therapy (TNT) is a novel approach for locally advanced rectal
cancer (LARC), which attempts to deliver both systemic chemotherapy and neoadjuvant …